Long-term outcomes of Omniflow II biosynthetic vascular graft in lower extremity arterial revascularization
- PMID: 32082771
- PMCID: PMC7018271
- DOI: 10.5606/tgkdc.dergisi.2018.15689
Long-term outcomes of Omniflow II biosynthetic vascular graft in lower extremity arterial revascularization
Abstract
Background: This study aims to evaluate the patency rates and long-term outcomes of femoro-popliteal bypass procedures with Omniflow II biosynthetic vascular grafts in patients with occlusive vascular disease.
Methods: This retrospective, observational, clinical study included a total of 93 patients (61 males, 32 females; mean age 56.9±7.4 years; range, 43 to 83 years) who underwent femoro-popliteal bypass in which Omniflow II biosynthetic vascular grafts were used due to peripheral arterial disease. The patients were divided into two groups: 62 patients undergoing femoro-popliteal above-knee bypass and 31 patients undergoing the femoro-popliteal belowknee bypass. We evaluated preoperative clinical characteristics, postoperative graft patency rates, and other clinical results.
Results: The mean follow-up was 44.9±18.8 months in the femoropopliteal above-knee bypass group and 47.3±22.3 months in the femoro-popliteal below-knee bypass group (p=0.302). The cumulative primary graft patency rates of the femoro-popliteal above-knee bypass and femoro-popliteal below-knee bypass groups at three, four, and five years were 98%, 95% and 78% and 86%, 75% and 45%, respectively (log-rank; p=0.312). The cumulative assisted graft patency rates of the femoro-popliteal above-knee bypass and femoro-popliteal below-knee bypass groups at five years were 87.9% and 65.3%, respectively (log-rank; p=0.530).
Conclusion: The Omniflow II biosynthetic vascular graft is suitable for above- and below-knee femoro-popliteal bypass procedures. These grafts may be prefered due to high patency rates, low incidence of aneursym formations, and infections.
Keywords: Biosynthetic graft; patency; revascularization.
Copyright © 2018, Turkish Society of Cardiovascular Surgery.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Figures



Similar articles
-
Outcomes of Omniflow® II prosthesis used for revascularization in the femoral tract both in infected and non-infected setting.J Cardiovasc Surg (Torino). 2023 Dec;64(6):634-644. doi: 10.23736/S0021-9509.23.12692-9. Epub 2023 Jun 12. J Cardiovasc Surg (Torino). 2023. PMID: 37306682
-
Omniflow II biosynthetic grafts versus expanded polytetrafluoroethylene grafts for infrainguinal bypass surgery. A single-center retrospective analysis.Vascular. 2022 Aug;30(4):749-758. doi: 10.1177/17085381211029815. Epub 2021 Jul 1. Vascular. 2022. PMID: 34210216
-
[Factors determining late patency of aortobifemoral bypass graft].Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):24-35. Srp Arh Celok Lek. 1997. PMID: 17974352 Serbian.
-
A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. J Vasc Surg. 2014. PMID: 24973288 Review.
-
Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.Int Angiol. 2004 Mar;23(1):54-65. Int Angiol. 2004. PMID: 15156131 Review.
References
-
- Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg. 2005;41:349–354. - PubMed
-
- Conte MS. The ideal small arterial substitute: a search for the Holy Grail. FASEB J. 1998;12:43–45. - PubMed
-
- Walluscheck KP, Bierkandt S, Brandt M, Cremer J. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results. J Cardiovasc Surg (Torino) 2005;46:425–430. - PubMed
-
- Jonas RA, Schoen FJ, Levy RJ, Castaneda AR. Biological sealants and knitted Dacron: porosity and histological comparisons of vascular graft materials with and without collagen and fibrin glue pretreatments. Ann Thorac Surg. 1986;41:657–663. - PubMed
-
- Robinson BI, Fletcher JP, Tomlinson P, Allen RD, Hazelton SJ, Richardson AJ, et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg. 1999;7:214–218. - PubMed
LinkOut - more resources
Full Text Sources